Reductions in exosomal PD-L1 during ICI have also been shown to correlate with radiographic evidence of tumor response on PET-CT and CT scans, suggesting that exosomal expression of PD-L1 is directly related to a patient’s response to ICI therapy (Cordonnier et al., 2020). The gene discussed is CD274; the disease is neoplasm.